Recent advancements in AI and Large Language Models (LLMs) have caught the world’s attention and for good reason. It’s a big deal. 

Specialty pharmaceuticals are typically costly, sometimes ranging from $10,000 to over $5 million per patient, per year. The onboarding and approval process that come with these drugs are complex, requiring extensive effort from manufacturers and patients to get enrolled. Despite massive investments in people, processes, and systems, engagement remains a struggle for all.

In this episode of Digital Conversations, Greg Johnsen and Greg Kefer discuss the implications of bringing conversational technology to the specialty pharma industry and how digital assistants use smart, compliant language to interact with patients and guide them along their journeys from prescription moment to program enrollment to first fill, and beyond.

The full power of conversational AI is being unleashed on the world through a steady stream of technological advancements, such as ChatGPT. It’s only a matter of time before language becomes the dominant interface between humans and machines. The healthcare industry will become one of the prime beneficiaries of this technology leap forward.

In this episode of Digital Conversations, Greg Kefer was joined by Sonam Shah, Director of Product Management at Lifelink Systems, who is developing advanced conversational AI for large healthcare organizations. Sonam shares her perspectives on what it takes to deliver desired outcomes in the context of high patient satisfaction. She also provides insights on how to overcome the array of complexity and compliance hurdles that are so prevalent in healthcare.

Business intelligence is a cornerstone of every digital transformation, with businesses spending $140B per year in analytics software. As conversational AI and digital engagement technology matures, a new domain of performance insights is emerging with the ability to measure every moment of the interaction between a business and its customers.

In this episode, Greg Kefer and Justin Mardjuki discuss the implication of new conversation-level insights for the healthcare industry. As provider systems, payers, and pharmaceutical companies deploy new conversational engagement channels for their patients, how can they best track and measure patient interaction to drive program improvements?